Related Experiment Video
Updated: Jun 4, 2025

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
Botulinum Toxin Treatment in Thyroid Eye Disease: A Systematic Review and Meta-analysis
Amanda M Zong1, Vasiliki P Giannakakos1, Caroline Delbourgo Patton2
1Department of Ophthalmology and Visual Sciences, Montefiore Medical Center, Albert Einstein College of Medicine.
Botulinum toxin effectively treats thyroid eye disease symptoms like lid retraction and strabismus. This review shows good success rates for retraction and some relief for strabismus, though surgery may still be needed.
Area of Science:
- Ophthalmology
- Neurology
Background:
- Thyroid eye disease (TED) presents challenges in managing lid retraction and strabismus.
- Botulinum toxin offers a potential non-surgical or adjunctive treatment option.
Purpose of the Study:
- To review the techniques, outcomes, and effectiveness of botulinum toxin in treating TED-related lid retraction and strabismus.
- To synthesize current evidence through a systematic review and meta-analysis.
Main Methods:
- Systematic review of studies on botulinum toxin for TED published up to May 2024.
- Meta-analysis of outcomes including marginal reflex distance change, diplopia resolution, need for further surgery, and side effects.
Main Results:
- Botulinum toxin (Botox/Dysport) showed an 84% success rate for lid retraction, decreasing marginal reflex distance by 2.42 mm for 1-6 months.
- 24% of strabismus patients experienced temporary diplopia resolution (2-6 months), with 58% requiring subsequent surgery.
- Reported side effects included ptosis and diplopia, primarily in retraction studies.
Conclusions:
- Botulinum toxin is an effective treatment for TED-related lid retraction and strabismus.
- Further randomized controlled trials are recommended to optimize treatment protocols.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Accessory Structures of the Eye

